Ensysce Biosciences, Inc. (ENSC) has 5 open-market insider trades by 2 insiders since 2022. Over the last six months insiders net bought $444K. The most active filer is Bob G. Gower, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Bob G. Gower | Dir | — | 4 | $1.7M | 2026-08-07 |
| Lynn Kirkpatrick | CEO | — | 1 | $49K | 2022-05-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bob G. Gower | Director | Buy | $444K | 2026-04-23 |
| Bob G. Gower | Director | Buy | $44K | 2023-03-02 |
| Bob G. Gower | Director | Buy | $183K | 2023-02-28 |
| Bob G. Gower | Director | Buy | $1.0M | 2022-12-09 |
| Lynn Kirkpatrick | CEO | Buy | $49K | 2022-05-25 |
Companies that share insiders with ENSC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.